Rafael Holdings, Inc. (RFL)
NYSE: RFL · Real-Time Price · USD
3.060
-0.090 (-2.86%)
Jul 6, 2026, 10:08 AM EDT - Market open
Rafael Holdings Revenue
Rafael Holdings had revenue of $179.00K in the quarter ending April 30, 2026, a decrease of -50.55%. This brings the company's revenue in the last twelve months to $980.00K, up 33.88% year-over-year. In the fiscal year ending July 31, 2025, Rafael Holdings had annual revenue of $917.00K with 43.96% growth.
Revenue (ttm)
$980.00K
Revenue Growth
+33.88%
P/S Ratio
167.14
Revenue / Employee
$42,609
Employees
23
Market Cap
159.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 917.00K | 280.00K | 43.96% |
| Jul 31, 2024 | 637.00K | - | - |
| Jul 31, 2023 | - | - | - |
| Jul 31, 2022 | 410.00K | -392.00K | -48.88% |
| Jul 31, 2021 | 802.00K | -4.11M | -83.67% |
| Jul 31, 2020 | 4.91M | -21.00K | -0.43% |
| Jul 31, 2019 | 4.93M | 560.00K | 12.81% |
| Jul 31, 2018 | 4.37M | -1.25M | -22.20% |
| Jul 31, 2017 | 5.62M | 29.00K | 0.52% |
| Jul 31, 2016 | 5.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Douglas Elliman | 993.99M |
| RE/MAX Holdings | 287.36M |
| Altisource Portfolio Solutions | 175.12M |
| Seaport Entertainment Group | 128.30M |
| Star Holdings | 124.46M |
| New England Realty Associates Limited Partnership | 94.12M |
| Comstock Holding Companies | 67.67M |
| American Realty Investors | 50.63M |
RFL News
- 25 days ago - Rafael Holdings Earnings release: Q3 2026 - Filings
- 25 days ago - Rafael Holdings Quarterly report: Q3 2026 - Filings
- 25 days ago - Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 26 days ago - Rafael Holdings reports completion of last patient visit for TransportNPC study - TheFly
- 26 days ago - Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C - GlobeNewsWire
- 2 months ago - Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease” - GlobeNewsWire
- 3 months ago - Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 3 months ago - Rafael Holdings Quarterly report: Q2 2026 - Filings